Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.
about
Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.Protein microarray applications: Autoantibody detection and posttranslational modification.Advances in the development of human protein microarrays.PMA: Protein Microarray Analyser, a user-friendly tool for data processing and normalization.
P2860
Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Development of a novel, quanti ...... ies to cancer-testis antigens.
@en
Development of a novel, quanti ...... ies to cancer-testis antigens.
@nl
type
label
Development of a novel, quanti ...... ies to cancer-testis antigens.
@en
Development of a novel, quanti ...... ies to cancer-testis antigens.
@nl
prefLabel
Development of a novel, quanti ...... ies to cancer-testis antigens.
@en
Development of a novel, quanti ...... ies to cancer-testis antigens.
@nl
P2093
P2860
P50
P356
P1476
Development of a novel, quanti ...... dies to cancer-testis antigens
@en
P2093
Aubrey Shoko
Jean-Michel Serufuri
Jessica Duarte
Jonathan Blackburn
P2860
P304
P356
10.1002/IJC.28832
P577
2014-03-24T00:00:00Z